Causal effects on non-terminal event time with application to antibiotic usage and future resistance
Tamir Zehavi, Uri Obolski, Michal Chowers, Daniel Nevo

TL;DR
This paper develops a new causal inference framework for non-terminal event times, specifically antibiotic resistance, using principal stratification and illness-death models, with application to clinical data.
Contribution
It introduces the infected-or-survivors principal stratum and the feasible-infection causal effect, expanding causal analysis in semi-competing risks settings.
Findings
Derived bounds for causal effects under novel assumptions
Identification of causal effects using illness-death models with frailty
Applied methods to real clinical data from a hospital study
Abstract
Comparing future antibiotic resistance levels resulting from different antibiotic treatments is challenging because some patients may survive only under one of the antibiotic treatments. We embed this problem within a semi-competing risks approach to study the causal effect on resistant infection, treated as a non-terminal event time. We argue that existing principal stratification estimands for such problems exclude patients for whom a causal effect is well-defined and is of clinical interest. Therefore, we present a new principal stratum, the infected-or-survivors (ios). The ios is the subpopulation of patients who would have survived or been infected under both antibiotic treatments. This subpopulation is more inclusive than previously defined subpopulations. We target the causal effect among these patients, which we term the feasible-infection causal effect (FICE). We develop…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Statistical Methods and Bayesian Inference · Health Systems, Economic Evaluations, Quality of Life
